Heartflow CFO sells 6,640 shares at $50.03

Heartflow’s CFO sold 6,640 HTFL shares under a pre-arranged Rule 10b5-1 trading plan and continues to hold over two hundred thousand shares.

Rhea-AI Filing Summary

Heartflow, Inc. (HTFL) reported that its Chief Financial Officer, Vikram Verghese, sold 6,640 shares of common stock on September 8, 2026 in an open-market transaction at a weighted average price of $50.0319 per share, with trades executed between $50.00 and $50.12.

After this sale, he held 214,503 shares of Heartflow common stock directly. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on June 4, 2026.

Insider Trade Summary 10b5-1

Net Seller: 6,640 shares

Net Sell 1 txn

Insider Verghese Vikram

Role Chief Financial Officer

Sold 6,640 shs ($332K)

Type	Security	Shares	Price	Value
Sale	Common Stock. F1, F2	6,640	$50.0319	$332K

Holdings After Transaction: Common Stock. — 214,503 shares (Direct)

Footnotes (2)

1. F1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2026.
2. F2. This transaction was executed in multiple trades at price ranging from $50.00 to $50.12. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Key Figures

Shares sold: 6,640 shares Weighted average sale price: $50.0319 per share Post-transaction holdings: 214,503 shares +2 more

5 metrics

Shares sold 6,640 shares Sale of Heartflow common stock by CFO on September 8, 2026

Weighted average sale price $50.0319 per share Average price for the 6,640 shares sold on September 8, 2026

Post-transaction holdings 214,503 shares Heartflow common stock held directly by CFO after the sale

Sale price range $50.00–$50.12 per share Range of individual trade prices within the reported sale

Rule 10b5-1 plan adoption date June 4, 2026 Date CFO adopted the trading plan used for the September 8, 2026 sale

Key Terms

Rule 10b5-1 trading plan, weighted average sale price, Form 4, open market or private transaction

4 terms

Rule 10b5-1 trading plan regulatory

"was effected pursuant to a Rule 10b5-1 trading plan adopted"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"The price reported above reflects the weighted average sale price"

Form 4 regulatory

"The transaction reported in this Form 4 was effected"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

open market or private transaction financial

"Sale in open market or private transaction"

FAQ

What insider transaction did HTFL report for its CFO on this Form 4?

Heartflow (HTFL) reported that CFO Vikram Verghese sold 6,640 shares of common stock on September 8, 2026 in an open-market transaction at a weighted average price of $50.0319 per share.

How many HTFL shares does the CFO hold after the reported sale?

After the reported transaction, CFO Vikram Verghese directly held 214,503 HTFL shares of common stock, according to the Form 4 disclosure.

At what prices were the HTFL shares sold in the CFO’s September 8, 2026 trade?

The Form 4 states the sale was executed in multiple trades at prices ranging from $50.00 to $50.12 per share, with a weighted average sale price of $50.0319 per share reported.

Was the HTFL CFO’s sale under a Rule 10b5-1 trading plan?

Yes. The filing notes the sale was effected pursuant to a Rule 10b5-1 trading plan that CFO Vikram Verghese adopted on June 4, 2026.

Does the Form 4 indicate whether the HTFL CFO’s trade was an open-market sale?

Yes. The transaction is described as a sale in open market or private transaction, with the Form 4 reporting it as a sale of common stock at market-based prices.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/10/2026 - 05:25 PM Accepted by SEC EDGAR 09/10/2026 - 05:24 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Verghese Vikram

(Last) (First) (Middle)

C/O HEARTFLOW, INC.

135 MAIN STREET, SUITE 1000

(Street)

SAN FRANCISCO CALIFORNIA 94105

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Heartflow, Inc. [ HTFL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock.	09/08/2026		S(1)		6,640	D	$50.0319(2)	214,503	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2026.

2. This transaction was executed in multiple trades at price ranging from $50.00 to $50.12. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

	/s/ Nga Van, by power of attorney	09/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)